Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer - Jia-Yi Deng; Ming Gao; Xue Fan; Hong-Hong Yan; Wei-Chi Luo; Ming-Yi Yang; Xiao-Rong Yang; Zhi-Hong Chen; Chong-Rui Xu; Qing Zhou (Cancer Immunology, Immunotherapy, 2025)